Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content

Shevchuk N.A.1 , Manela J.2, Nusinovich Ye.A.1, Ladisch S.1

1. Center for Cancer and Immunology Research, Children's Research Institute Molecular and Cellular Oncology Program, Institute for Biomedical Sciences, The George Washington University
2. Center for Cancer and Immunology Research, Children's Research Institute Human Genome Sciences, Inc
Section: Experimental/Clinical Study
UDK: 577.155+577.151.042+575.224.46      PubMed Id: 16898583
Year: 2006  Volume: 52  Issue: 3  Pages: 245-257
Tumor cell gangliosides are bioactive molecules involved in tumor-host interactions. To investigate their role in tumor formation and angiogenesis, we sought to develop an inhibitory model targeting human GM3 synthase, an essential enzyme in the ganglioside synthesis pathway, by antisense transfection. We prepared a number of transfectants from DAOY human medulloblastoma cells and isolated clones that stably expressed a 560-bp fragment of human GM3 synthase cDNA, in either sense or antisense orientation, as well as clones transfected with an empty vector. Both sense and antisense clones permanently incorporated mammalian expression vectors into their genomes. The DAOY cell clones were screened for ganglioside content using total lipid extraction, ganglioside isolation, and HPTLC. One antisense- transfected clone, 7.2A, in which total ganglioside content was reduced by 70%, was selected for further study. All sense- and sham-transfectants had ganglioside levels not different from that of untransfected DAOY cells. After 10 passages however, while antisense mRNA expression was fully maintained, the ganglioside content of 7.2A cells had reverted to normal levels. Antisense RNA transfection can sometimes have a reversible effect on the expression of a target. Possible regulatory mechanisms of this previously unrecognized process of reversion to wild type phenotype are discussed.
Download PDF:

Shevchuk N.A., Manela J., Nusinovich Ye.A., Ladisch S. (2006) Biomeditsinskaya khimiya, 52(3), 245-257.
This paper is also available as the English translation:10.1134/S1990750807010106
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)

© Institute of Biomedical Chemistry, Moscow, Russia